Innovative Drug Discovery and Nanotechnology (Track)
A GENETICALLY-ENCODED FRET SENSOR FOR LACTATE: A NEW TOOL FOR CANCER DRUG
DISCOVERY
San Martín, A, Ceballo, S., Ruminot, I., Lerchundi, R., Frommer, W.B. & Barros,
L.F.
Biophysic and Molecular Physiology, Center for Scientific Studies
Abstract:
Lactate is a metabolic marker of cancer. In cancer cells mitochondrial function is impaired and most
energy is produced via glycolysis, resulting in highly increased production and release of lactate, a
phenomenon known as the Warburg effect. Current methods to measure cancer cell metabolism rely
on estimation of oxygen consumption in cell populations with limited temporal resolution.
In order to measure lactate in single cells with temporal resolution of seconds, we engineered a genetically-encoded
Forster Resonance Energy Transfer (FRET)-based Lactate nanosensor designed on the bacterial transcription factor
LldR. The sensor, termed Laconic, quantified lactate between 1 μM to 10 mM, spanning physiological and pathological
concentrations. Used in combination with ad hoc transporter-block protocols, Laconic allowed for the first time singlecell
estimation of two important metabolic parameters: the rate of cellular lactate production and the rate of
mitochondrial metabolism. The ratio between lactate production and mitochondrial metabolism, which we have termed
Warburg index, was identified as a very sensitive parameter of anomalous metabolism in cancer cells. We envisage that
the lactate sensor and associated protocols may be amenable for high-throughput format, for example for cancer drug
discovery (PCT/US12/33639).